[1] |
Gross JL, de Azevedo MJ, Silveiro SP, et al. Diabetic nephropathy: diagnosis, prevention, and treatment[J]. Diabetes Care, 2005, 28 (1): 164-176.
|
[2] |
Lim AKh. Diabetic nephropathy-complications and treatment[J]. Int J Nephrol Renovasc Dis, 2014, 7: 361-381.
|
[3] |
Kantharidis P, Wang B, Carew RM, et al. Diabetes complications: the microRNA perspective[J]. Diabetes, 2011, 60 (7): 1832-1837.
|
[4] |
Trionfini P, Benigni A, Remuzzi G. MicroRNAs in kidney physiology and disease[J]. Nat Rev Nephrol, 2015, 11 (1): 23-33.
|
[5] |
Kriegel AJ, Fang Y, Liu Y, et al. MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382[J]. Nucleic Acids Res, 2010, 38 (22): 8338-8347.
|
[6] |
Kriegel AJ, Liu Y, Cohen B, et al. MiR-382 targeting of kallikrein 5 contributes to renal inner medullary interstitial fibrosis[J]. Physiol Genomics, 2012, 44 (4): 259-267.
|
[7] |
Sánchez-Romero N, Schophuizen CMS, Giménez I, et al. In vitro systems to study nephropharmacology: 2D versus 3D models[J]. Eur J Pharmacol, 2016, 790: 36-45.
|
[8] |
Seok JK, Lee SH, Kim MJ, et al. MicroRNA-382 induced by HIF-1 alpha is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog[J]. Nucleic Acids Res, 2014, 42 (12): 8062-8072.
|
[9] |
Schnaper HW, Hayashida T, Hubchak SC, et al. TGF-beta signal transduction and mesangial cell fibrogenesis[J]. Am J Physiol Renal Physiol, 2003, 284 (2): F243-F252.
|
[10] |
Chen T, Ren H, Thakur A, et al. miR-382 inhibits tumor progression by targeting SETD8 in non-small cell lung cancer[J]. Biomed Pharmacother, 2017, 86: 248-253.
|
[11] |
Tan H, He Q, Gong G, et al. miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer[J]. Int J Oncol, 2016, 48 (1): 181-190.
|
[12] |
Kato M, Wang M, Chen Z, et al. An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy[J]. Nat Commun, 2016, 7: 12864.
|
[13] |
Fang Y, Xie T, Xue N, et al. miR-382 Contributes to renal tubulointerstitial fibrosis by downregulating HSPD1[J]. Oxid Med Cell Longev, 2017, https://doi.org/10.1155/2017/4708516.
|
[14] |
Wang S, Wen X, Han XR, et al. Repression of microRNA-382 inhibits glomerular mesangial cell proliferation and extracellular matrix accumulation via FoxO1 in mice with diabetic nephropathy[J]. Cell Prolif, 2018, 51 (5): e12462.
|
[15] |
Dey N, Bera A, Das F, et al. High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression[J]. Cell Signal, 2015, 27 (7): 1276-1285.
|
[16] |
Bera A, Das F, Ghosh-Choudhury N, et al. Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion[J]. Am J Physiol Cell Physiol, 2017, 313 (4): C430-C447.
|
[17] |
de Lima E Santos C, Arnoni CP, Schor N, et al. Effects of glucose deprivation or glucose instability on mesangial cells in culture[J]. Am J Nephrol, 2009, 29 (3): 222-229.
|
[18] |
Hu B, Yang Z, Yu L, et al. 3D hypoxia microenvironment created by a single cell layer-by-layer assembly spheroid demonstrates the role of miR-382 and cell autophagy in renal fibrosis[J]. J Biomed Nanotechnol, 2018, 14 (2): 331-343.
|